Our catalog lists 30 products that may treat carcinoma, renal cell, drawn from FDA drug-class data. Each is independently rated; the current top-rated option is thalomid.
What is the best-rated treatment for carcinoma, renal cell?
By our independent rating, thalomid currently ranks highest for carcinoma, renal cell. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Treatment associations are derived from FDA drug-class data (RxClass “may treat”). This is general reference, not medical advice — always consult a licensed professional.
xromi
PrescriptionFDA-sourced
New
Antimetabolite used to treat brain neoplasms, carcinoma, non-small-cell lung, carcinoma, renal cell.